Replies to post #11443 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

MNTA's FoB partnership will be with BAX's yet-to-be-named spinoff, who might be more inclined to pursue FoB's aggressively than the existing BAX; however, I don't think this is a significant change for MNTA one way or the other.